Case Investigations

Adobe Systems, Inc.

San Francisco – October 11, 2013 - Kaplan Fox & Kilsheimer LLP is investigating potential claims involving Adobe Systems Inc.’s public announcement on October 3, 2013 that it had discovered “sophisticated attacks” on its network, “involving the illegal access of customer information."

Crestor® (rosuvastatin calcium)

May 25, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating the statin drug Crestor® (rosuvastatin), a cholesterol-lowering medication, approved by the Food and Drug Administration for use by the public in August 2003.